Netherlands· NL-fce0f9604758

Nilemdo 180 mg, filmomhulde tabletten

A bempedoic acid product containing bempedoïnezuur, registered in Netherlands by DAIICHI SANKYO EUROPE GmbH. The same ATC class is registered in 13 of our 19 countries.

ATC C10AX15

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about bempedoïnezuurAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Bempedoic acid is registered in 13 of 19 countries.

Countries holding a registration under ATC C10AX15 (bempedoic acid), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search bempedoic acid products by name

Bempedoic acid · ATC C10AX15

13 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bempedoic acid costs, country by country.

Normalised to the WHO defined daily dose (0.18 g), the median price runs from $2.64 in Switzerland to $4.54 in Italy — a ×1.7 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Bempedoic acid · price per daily dose (0.18 g)

USD · FX 28 Sept 2026

IT Italy$4.54
CH Switzerland$2.64

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: BEMPEDOÏNEZUUR
Manufacturer: DAIICHI SANKYO EUROPE GmbH
Country: Netherlands (NL)
ATC code: C10AX15
ATC class: Bempedoic acid
Defined daily dose: 0.18 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/20/1425

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

35 interactions on record for bempedoic acid.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check bempedoic acid against other medicines How interaction checks work

Bempedoic acid · interactions on record

35 records

20 severe
15 moderate

Most severe, free to view

PrednisoloneA07EA01severe
HydrocortisoneA07EA02severe
PrednisoneA07EA03severe
BetamethasoneA07EA04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bempedoic acid in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bempedoic acid products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

Iceland · Nilemdo
Liechtenstein · Nilemdo
Norway · Nilemdo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/99ad64ec-24f7-4372-a13b-5b58bd962f3b
GET /v1/drugs/99ad64ec-24f7-4372-a13b-5b58bd962f3b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/nilemdo-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Bempedoic acid",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp124563",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYPROLOSE (E 463)",
    "LACTOSE 1-WATER",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "POLYVINYLALCOHOL, GEDEELTELIJK GEHYDROLYSEERD (E1203)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "BEMPEDOÏNEZUUR"
  ],
  "leaflet_url": null,
  "authorised_at": "2020/04/01",
  "procedure_number": "EMEA/H/C/004958",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/20/1425",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about bempedoic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console